drugset / Trial / NCT00127257

Biofeedback for Dyssynergic Constipation

NCT00127257

RandomizedParallel-groupSingle-blindTreatment

Summary

Constipation affects 4% of adults in the United States (U.S.). An estimated half of constipated patients are unable to relax pelvic floor muscles during defecation, a type of constipation called pelvic floor dyssynergia (PFD). Biofeedback has been recommended for the treatment of constipation because uncontrolled studies over the past 10 years suggest that these treatments are as effective as medical or surgical management and involve no risk. However, placebo-controlled trials are still lacking. The aims of this study are: * to compare biofeedback to alternative therapies for which patients have a similar expectation of benefit; * to identify which patients are most likely to benefit; and * to assess the impact of treatment on quality of life.

Timeline

Start
1999-09
Primary completion
Completion
2006-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 5 mg

Indications